Publications by authors named "Barbara McCoy"

Claim this Profile
E
Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases.
Niraj C Patel, Jolan E Walter, Richard L Wasserman, Arye Rubinstein, Suthida Kankirawatana, Barbara McCoy

J Clin Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study.
Pauline M Ellerbroek, Leif G Hanitsch, Torsten Witte, Vassilios Lougaris, P Martin van Hagen, Barbara McCoy

Immunotherapy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.
Peter Čižnár, Marion Roderick, Helen Schneiderova, Miloš Jeseňák, Gergely Kriván, Barbara McCoy

Allergy Asthma Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.
Hirokazu Kanegane, Akifumi Endo, Satoshi Okada, Hidenori Ohnishi, Masataka Ishimura, Barbara McCoy

Immunother Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of facilitated subcutaneous immunoglobulin treatment in pregnant women with primary immunodeficiency diseases: results from a registry study.
Michael Borte, Stefan Raffac, Martin Hrubiško, Karina Jahnz-Rozyk, Enrique Garcia, Barbara McCoy

Immunotherapy· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic simulation of varied Immune Globulin Subcutaneous (Human), 20% solution (Ig20Gly) loading and maintenance dosing regimens in immunoglobulin-naïve patients with primary immunodeficiency diseases.
Zhaoyang Li, Todd Dumas, N Seth Berry, Barbara McCoy, Leman Yel

Int Immunopharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-State Serum IgG Trough Levels Are Adequate for Pharmacokinetic Assessment in Patients with Immunodeficiencies Receiving Subcutaneous Immune Globulin.
Zhaoyang Li, Barbara McCoy, Werner Engl, Leman Yel

J Clin Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials.
Lisa M Meckley, Yanyu Wu, Diane Ito, Todd Berner, Barbara McCoy

BMC Immunol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases.
Sudhir Gupta, Mark Stein, Iftikhar Hussain, Kenneth Paris, Werner Engl, Barbara McCoy

Ann Allergy Asthma Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents.
Daniel Suez, Gergely Kriván, Stephen Jolles, Mark Stein, Sudhir Gupta, Barbara McCoy

Immunotherapy· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases.
Todd Dumas, N Seth Berry, Martin Wolfsegger, Stephen Jolles, Barbara McCoy

Int Immunopharmacol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies.
Kenneth Paris, Elie Haddad, Michael Borte, Nicholas Brodszki, Beáta Dérfalvi, Barbara McCoy

Immunotherapy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
Daniel Suez, Mark Stein, Sudhir Gupta, Iftikhar Hussain, Isaac Melamed, Barbara McCoy

J Clin Immunol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.
Daniel Suez, Mark Stein, Sudhir Gupta, Iftikhar Hussain, Isaac Melamed, Barbara McCoy

J Clin Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study.
Bohumír Blažek, Siraj A Misbah, Pere Soler-Palacin, Barbara McCoy, Heinz Leibl

Immunotherapy· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
Richard L Wasserman, Isaac Melamed, Mark R Stein, Sudhir Gupta, Jennifer Puck, Barbara McCoy

J Allergy Clin Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating evidence into practice: the case of dementia guidelines in specialized geriatric services.
David L Lewis, David Jewell, Irene Turpie, Christopher Patterson, Barbara McCoy

Can J Aging· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis